Expertise

Nikola is an associate with a primary focus on corporate and M&A, employment and commercial matters.

Nikola joined Radovanović Stojanović & Partners after graduating from the University of Belgrade, where he obtained his LLB degree.

Publications

Admissions

Recognitions

Languages

Serbian, English, German

Memberships

Related Insights

Newsroom
Law on e-Sick Leave - The Digitalization of Sick Leave Administration in Serbia
Legal Blog

Law on e-Sick Leave - The Digitalization of Sick Leave Administration in Serbia law-on-e-sick-leave---the-digitalization-of-sick-leave-administration-in-serbia

On 12 December 2025, the Law on the Exchange of Data, Documents and Notifications in Cases of Temporary Incapacity for Work Using the “e-Sick Leave – Employer” Software Solution (“Law”), entered into force.

legal-blog
Employee Insurance under the New Law on Occupational Health and Safety – What Employers Need to Know Before May 2025
Legal Blog

Employee Insurance under the New Law on Occupational Health and Safety – What Employers Need to Know Before May 2025employee-insurance-under-the-new-law-on-occupational-health-and-safety---what-employers-need-to-know-before-may-2025

On 28 April 2023, the National Assembly of the Republic of Serbia adopted a new Law on Occupational Health and Safety ("Law"). Although the Law formally entered into force on 7 May 2023, its full application was postponed until 7 May 2025, providing employers with a transitional period to harmonize their operations with the new requirements.

Nikola CincovićNikola Cincović
legal-blog
Rejection of Roche/ADOC exclusivity exemption: A sign of a stricter approach of the Serbian competition authority?
Legal Blog

Rejection of Roche/ADOC exclusivity exemption: A sign of a stricter approach of the Serbian competition authority?rejection-of-roche-adoc-exclusivity-exemption-a-sign-of-a-stricter-approach-of-the-serbian-competition-authority

The Serbian Commission for Protection of Competition (CPC) has denied Roche and ADOC's request to extend their exclusive distribution agreement exemption, marking a significant shift in regulatory oversight. This July 2024 decision affects the distribution of three crucial pharmaceuticals: Kadcyla, Perjeta, and Tecentriq.

Raško RadovanovićRaško Radovanović
legal-blog
Radovanović Stojanović & Partners advises British American Tobacco on the sidestream merger of its Serbian subsidiaries
News

Radovanović Stojanović & Partners advises British American Tobacco on the sidestream merger of its Serbian subsidiariesradovanovic-stojanovic-partners-advises-british-american-tobacco-on-the-sidestream-merger-of-its-serbian-subsidiaries

Radovanović Stojanović & Partners advised British American Tobacco on a sidestream merger of its Serbian subsidiaries British American Tobacco South-East Europe doo Beograd (as the transferring entity) and British American Tobacco Vranje ad (as the surviving entity).

RS PartnersRS Partners
news
1–3